T. Economopoulos

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

Meletios Α. Dimopoulos, Athanasios K. Anagnostopoulos, Marie‐Christine Kyrtsonis et al. · Journal of Clinical Oncology · 2007 · 277 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

P. Kosmidis, Nick Mylonakis, C. Nicolaides et al. · Journal of Clinical Oncology · 2002 · 255 citations

Medicine, Oncology, Pharmacology +17

A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group

Eric Wattel, A. Guerci, B Hecquet et al. · Blood · 1996 · 157 citations · Full text

Medicine, Hematology, Oncology +17

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases

John Dervenoulas, Panagiotis Tsirigotis, G. Bollas et al. · Annals of Hematology · 2000 · 63 citations

Medicine, Hematology, Internal Medicine +13

Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)

Efstathios Kastritis, Marie‐Christine Kyrtsonis, Evdoxia Hadjiharissi et al. · Leukemia Research · 2010 · 61 citations

Pharmacy, Pathology, Clinical Biochemistry +9